Idiopathic multicentric Castleman's disease. Features of radiological imaging with postprocessing. Presentation of own observation
https://doi.org/10.36604/1998-5029-2024-92-100-106
Abstract
Idiopathic multicentric Castleman's disease (iMCD) is one of the subtypes of a rare non-clonal lymphoproliferative disorder affecting lymph nodes of various groups. This article discusses the diagnostic features of iMCD using multislice computed tomography (MSCT) and suggests parameters for postprocessing. A case of iMCD complicated by broncholithiasis, with effective visualization of changes using MSCT technique including images of multiplanar reconstruction and volume rendering, is demonstrated.
About the Authors
A. V. Lenshin
Far Eastern Scientific Center of Physiology and Pathology of Respiration
Russian Federation
Russian Federation
Anatoliy V. Lenshin, MD, PhD, DSc (Med.), Professor, Roentgenologist, Leading Staff Scientist of Laboratory of Functional Research of Respiratory System
22 Kalinina Str., Blagoveshchensk, 675000
A. V. Il’in
Far Eastern Scientific Center of Physiology and Pathology of Respiration
Russian Federation
Russian Federation
Andrey V. Il’in, PhD (Med.), Roentgenologist, Head of Department of X-Ray Diagnostics
22 Kalinina Str., Blagoveshchensk, 675000
E. A. Ignat’eva
Far Eastern Scientific Center of Physiology and Pathology of Respiration
Russian Federation
Russian Federation
Elena A. Ignat’eva, Roentgenologist of Department of X-Ray Diagnostics
22 Kalinina Str., Blagoveshchensk, 675000
Yu. M. Perelman
Far Eastern Scientific Center of Physiology and Pathology of Respiration
Russian Federation
Russian Federation
Juliy M. Perelman, MD, PhD, DSc (Med.), Corresponding Member of RAS, Professor, Deputy Director on Scientific Work, , Head of Laboratory of Functional Research of Respiratory System
22 Kalinina Str., Blagoveshchensk, 675000
References
1. Liu A.Y., Nabel C.S., Finkelman B.S., Ruth J.R., Kurzrock R., van Rhee F., Krymskaya V.P., Kelleher D., Rubenstein A.H., Fajgenbaum D.C. Idiopathic multicentric Castleman’s disease: A systematic literature review. Lancet Haematol. 2016; 3:163–175. https://doi.org/10.1016/S2352-3026(16)00006-5
2. Carbone A., Borok M., Damania B., Gloghini A., Polizzotto M.N., Jayanthan R.K., Fajgenbaum D.C., Bower M. Castleman disease. Nat. Rev. Dis. Primers. 2021; 7:84. https://doi.org/10.1038/s41572-021-00317-7
3. Lang E., van Rhee F. Idiopathic multicentric Castleman disease: An update in diagnosis and treatment advances. Blood Rev. 2024; 64:101161. https://doi.org/10.1016/j.blre.2023.101161
4. Vasilyev V.I., Palshina S.G., Pavlovskaya A.I., Kokosadze N.V., Chaltsev B.D., Shornikova L.A. [Idiopathic multicentric Castleman's disease]. Terapevticheskiy arkhiv 2020; 92(5):78–84 (in Russian). https://doi.org/10.26442/00403660.2020.05.000440
5. Mihajlov A.M., Bessmel'cev S.S., Semenova N.Ju., Hmel'nickaja N.M., Odin V.I., Poljakov A.S. [Idiopathic, HIV and herpes virus-8-negative Castleman's Disease as an autoimmune productive vasculitis]. Gematologiya i transfuziologiya = Russian journal of hematology and transfusiology 2022; 67(S2):255 (in Russian).
6. Feigenbaum D.K., Uldric T.S., Bagg A., Frank D, Wu D., Srkalovic G, Simpson D., Liu A.Y., Menke D., Chandrakasan S., Lechowicz M.J., Wong R.S.M., Pierson S., Paessler M., Rossi J., Ide M., Ruth J., Croglio M., Suarez A., Krymskaya V., Chadburn A., Colleoni G., Nasta S., Jayanthan R., Nabel C.S., Casper C., Dispenzieri A., Fossa A, Kelleher D., Kurzrock R., Voorhees P., Dogan A., Yoshizaki K., van Rhee F., Oksenhendler E., Jaffe E.S., Elenitoba-Johnson K., Lim M.S. International evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood 2017; 129(12): 1646–1657. https://doi.org/10.1182/blood-2016-10-746933
7. Mukherjee S., Martin R., Sande B., Paige J., Fajgenbaum D. Epidemiology and treatment features of idiopathic multicentric Castleman disease in the era of IL-6-targeted therapy. Blood Adv. 2022; 6(2):359–367. https://doi.org/10.1182/bloodadvances.2021004441
8. Castleman B., Iverson D., Menendez V.P. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 1956; 9(4):822–830. https://doi.org/10.1002/1097-0142(195607/08)9:43.0.co;2-4
9. van Rhee F., Munshi N.C. Castleman Disease // Hematol. Oncol. Clin. North. Am. 2018; 32(1):13–14. https://doi.org/10.1016/j.hoc.2017.10.001
10. Madan R., Chen J.H., Trotman-Dickenson B. The spectrum of Castleman's disease: mimics, radiologic pathologic correlation and role of imaging in patient management. Eur. J. Radiol. 2012; 81(1):123–131. https://doi.org/10.1016/j.ejrad.2010.06.018
11. Hill A.J., Tirumani S.H., Rosenthal M.H., Shinagare A.B., Carrasco R.D., Munshi N.C., Ramaiya N.H. Multimodality imaging and clinical features in Castleman disease: single institute experience in 30 patients. Br. J. Radiol. 2015; 88(1049):20140670. https://doi.org/10.1259/bjr.20140670
12. Huang H., Feng R, Li J, Song X, Li S, Xu K, Cao J, Zhang L, Bi Y, Xu Z. Castleman disease-associated diffuse parenchymal lung disease. Medicine (Baltimore) 2017; 96(39): e8173. https://doi.org/10.1097/MD.0000000000008173
13. Kligerman S.J., Auerbach A., Franks T.J., Galvin J.R. Castleman Disease of the thorax: clinical, radiologic and pathologic correlation: from the radiologic. Radiographics 2016; 36(5):1309–1332. https://doi.org/10.1148/rg.2016160076
14. Simpson D. Epidemiology of Castleman disease. Hematol. Oncol. Clin. North. Am. 2018; 32(1):1–10. https://doi.org/10.1016/j.hoc.2017.09.001
15. Dispenzieri A., Fajgenbaum D.C. Overview of Castleman disease. Blood. 2020; 135(16):1353–1364. https://doi.org/10.1182/blood.2019000931
Review
For citations:
Lenshin A.V., Il’in A.V., Ignat’eva E.A., Perelman Yu.M. Idiopathic multicentric Castleman's disease. Features of radiological imaging with postprocessing. Presentation of own observation. Bulletin Physiology and Pathology of Respiration. 2024;(92):100-106. (In Russ.) https://doi.org/10.36604/1998-5029-2024-92-100-106
Views:
252
Email this article 